A public consultation on the future of the Nuffield Speech and Language Unit has been launched by NHS Ealing.
The unit was run by the Royal National Throat, Nose and Ear Hospital (RNTNEH), part of the Royal Free Hampstead NHS Trust, and helped children with severe speech and language problems with a focus on development verbal dyspraxia (DVD). In 2007 services at the unit were suspended and since then there has been a series of discussions about its future, involving a wide range of people and organisations.
NHS Ealing wants to hear the views of pupils and parents or carers, colleagues in health and education, speech and language professionals and the wider public. There are six different proposals for the future of the services that were provided by the unit. The full consultation document and supporting information are available on the NHS Ealing website.
You can have your say by:
Joining a focus group:
16 March, 2pm to 4pm, Ealing Town Hall, Uxbridge Road, London W5 2BY.
Dropping in on a conversation café:
2 February, 10.30am until 12.30pm, or 2 March, 6pm to 8pm, Ealing Town Hall, Uxbridge Road, London W5 2BY.
9 March, 12pm to 2pm, Board Room, National Throat, Nose and Ear Hospital, 330 Gray’s Inn Road, London WC1X 8DA.
You can also fill in a questionnaire online.
Please note that this consultation is exclusively about services provided in Ealing. There will be no change to service provided at the RNTEH.
The closing date for responses and submissions is 5pm on Friday 25 March 2011.
Notes to editors
1. For more information, contact name on 020 7317 7590 or email: email@example.com
2. The Royal Free is Dr Foster’s ‘large trust of the year’ for 2010. Our services have been rated “excellent” for the third year running, most recently by the Care Quality Commission. The trust attracts patients from across the country and beyond to its specialist services in liver, kidney and bone marrow transplantation, surgery for hepatopancreatobiliary (HPB) conditions, clinical neurosciences, renal, HIV, infectious diseases, plastic surgery, immunology, vascular surgery, cardiology, amyloidosis and scleroderma and are a member of the academic health science partnership UCL Partners. For further information, visit www.royalfree.nhs.uk